Esteban Masuda
2017
In 2017, Esteban Masuda earned a total compensation of $638.4K as Executive Vice President, Research at Rigel Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $168,000 |
|---|---|
| Option Awards | $131,182 |
| Salary | $336,000 |
| Other | $3,196 |
| Total | $638,378 |
Masuda received $336K in salary, accounting for 53% of the total pay in 2017.
Masuda also received $168K in non-equity incentive plan, $131.2K in option awards and $3.2K in other compensation.
Rankings
In 2017, Esteban Masuda's compensation ranked 10,970th out of 14,666 executives tracked by ExecPay. In other words, Masuda earned more than 25.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,970 out of 14,666 | 25th |
Division Manufacturing | 4,287 out of 5,768 | 26th |
Major group Chemicals And Allied Products | 1,545 out of 2,074 | 26th |
Industry group Drugs | 1,265 out of 1,730 | 27th |
Industry Pharmaceutical Preparations | 984 out of 1,329 | 26th |
Source: SEC filing on April 1, 2020.
Masuda's colleagues
We found five more compensation records of executives who worked with Esteban Masuda at Rigel Pharmaceuticals in 2017.
2017
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2017
Dolly Vance
Rigel Pharmaceuticals
General Counsel
2017
Ryan Maynard
Rigel Pharmaceuticals
Chief Financial Officer
2017
Anne-Marie Duliege
Rigel Pharmaceuticals
Chief Medical Officer
2017
Eldon Mayer
Rigel Pharmaceuticals